Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Amifostine Safety Study
NCT00158041Phase 4Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amifostine in acute radiation syndrome (ARS), sponsored by Mount Sinai Medical Center. Started Jan 2002; status: completed.
02
Drugs
amifostine
03
Conditions
acute radiation syndrome (ARS)
Beyond the preview
Go deeper on NCT00158041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158041.